CTLA4 and renal cell carcinoma: With the approval of ICI blockade in metastatic RCC, is there a biomarker for CTLA-4? There is strong evidence that the DNA methylation of the gene encoding for the CTLA4 protein predicts response to anti-PD-1 and anti-CTLA-4 in patients with melanoma and RCC.